The estimated Net Worth of Thomas B Smith is at least 1.4 百万$ dollars as of 29 February 2024. Mr. Smith owns over 995 units of Biodelivery Sciences International stock worth over 354,456$ and over the last 6 years he sold BDSI stock worth over 36,576$. In addition, he makes 1,013,450$ as Chief Medical Officer at Biodelivery Sciences International.
Thomas has made over 3 trades of the Biodelivery Sciences International stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 995 units of BDSI stock worth 36,576$ on 29 February 2024.
The largest trade he's ever made was exercising 32,576 units of Biodelivery Sciences International stock on 27 January 2022 worth over 182,100$. On average, Thomas trades about 4,124 units every 149 days since 2018. As of 29 February 2024 he still owns at least 63,409 units of Biodelivery Sciences International stock.
You can see the complete history of Mr. Smith stock trades at the bottom of the page.
Thomas (Tom) B. Smith M.D., is the Chief Medical Officer of the Company. His extensive and wide-ranging roles include having served as Chief Medical Officer at various leading pain companies, head of medical affairs at top tier pharma and CRO companies, as well as running his own private practice. Dr. Smith served as Chief Medical Officer at Charleston Labs, Inc., from January 2017 to July 2018 and from October 2014 to January 2017, he served as the Chief Medical Officer of Ameritox, Ltd. Dr. Smith previously served as Chief Medical Officer for Mallinckrodt Pharmaceuticals from 2012 to 2014 and held clinical leadership roles at Abbott Laboratories, Teva Pharmaceuticals, Kendle International, Akros Pharma and Genzyme during 2001 to 2014. Dr. Smith earned a Doctor of Medicine degree from the Indiana University School of Medicine and a Bachelor of Science degree from Purdue University. He is a member of several medical societies and organizations including the American Medical Association and the American Academy of Family Physicians. Dr. Smith is a highly published scientific author and has delivered more than 150 presentations in his field of expertise.
As the Chief Medical Officer of Biodelivery Sciences International, the total compensation of Thomas Smith at Biodelivery Sciences International is 1,013,450$. There are 2 executives at Biodelivery Sciences International getting paid more, with Scott Plesha having the highest compensation of 1,503,860$.
Thomas Smith is 59, he's been the Chief Medical Officer of Biodelivery Sciences International since 2018. There are 3 older and 10 younger executives at Biodelivery Sciences International. The oldest executive at Biodelivery Sciences International is William Watson, 69, who is the Independent Director.
Thomas's mailing address filed with the SEC is 4131 Parklake Ave #225, Raleigh, NC 27612, USA.
Over the last 21 years, insiders at Biodelivery Sciences International have traded over 111,671,776$ worth of Biodelivery Sciences International stock and bought 1,813,177 units worth 5,352,510$ . The most active insiders traders include International, L.P. Elliott、Associates, L.P. Elliott、Healthcare Master Fund Ltd .... On average, Biodelivery Sciences International executives and independent directors trade stock every 18 days with the average trade being worth of 420,648$. The most recent stock trade was executed by Jeffrey Allen Bailey on 9 March 2022, trading 5,333 units of BDSI stock currently worth 29,811$.
BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.
Biodelivery Sciences International executives and other stock owners filed with the SEC include: